Benzinga | Dec 18, 2020 06:06AM EST

Danaher's Beckman Coulter Announces Launch Of Access SARS-CoV-2 Antigen Assay COVID-19 Antigen Test

BREA, Calif., Dec. 18, 2020 /PRNewswire/ -- Beckman Coulter, a leader in clinical diagnostics, today announced the launch of a new test that addresses the three main barriers currently facing schools, businesses, hospitals and communities with the rollout of mass COVID-19 testing. The new Access SARS-CoV-2 Antigen assay is the first cost-effective high-quality, high-throughput COVID-19 test available in the U.S. with the volume, workflow and scalable flexibility needed to help fight the COVID-19 pandemic.